What’s happening with the American Roentgen Ray Society? Its annual meeting, known mainly for the quality of its refresher course, has become an essential point of coverage for world-class scientific research as well.
What's happening with the American Roentgen Ray Society? Its annual meeting, known mainly for the quality of its refresher course, has become an essential point of coverage for world-class scientific research as well.Colleagues at Diagnostic Imaging have handled our review of ARRS abstracts in the past, so I was more than a little surprised by the high level of scientific achievement evident at this year's show. I assumed I could breeze through the program to find a newsworthy abstract or two per day for daily news coverage on DiagnosticImaging.com. Was I ever wrong! Three hours passed, and I was still summarizing excellent trials deserving coverage.
Here are a few samples of the scientific papers presented at the 2008 conference:
I could speculate at length about the reasons for why the ARRS meeting presentations have improved to such a degree. The change may reflect the general enrichment of medical imaging research.
The ARRS's improvements may suggest that the RSNA meeting's cup has finally runneth over. Attendees complain year after year that the society's annual conference has grown too large. Important studies that are lost in the shuffle of 100,000 feet in Chicago can earn deserved attention at the smaller ARRS meeting. The globalization of radiological research has also been a generally positive influence.Whatever the cause, the effect has elevated the quality of the ARRS meeting. More than ever, the meeting deserves your attention.
Mammography Study Suggests DBT-Based AI May Help Reduce Disparities with Breast Cancer Screening
December 13th 2024New research suggests that AI-powered assessment of digital breast tomosynthesis (DBT) for short-term breast cancer risk may help address racial disparities with detection and shortcomings of traditional mammography in women with dense breasts.
Mammography News: FDA Grants Expanded 510(k) Clearance for AI-Powered SmartMammo Dx DBT Software
November 29th 2024Originally cleared by the FDA in 2021, the SmartMammo Dx software for digital breast tomosynthesis (DBT) can now be utilized with the Senographe Pristina mammography systems from GE HealthCare.